DIMENSION

Reflecting on 2024: a category sweep of the Nobels, AI enabled clinical readouts, and the first trillion dollar pharma in sight.

We stand on the shoulders of giants. Looking to 2025: This is just the beginning. Make no small plans.

Today we’re announcing Darsh Patel has officially joined Dimension. @darsh_cp spent the last 4 years at Bessemer Venture Partners, and will help lead investments across the frontiers of science through to cutting edge compute and infrastructure. Welcome to the team Darsh!!

Congrats to Gary Glick and the entire Odyssey Therapeutics team on today’s upsized IPO! We’re thrilled to deepen our partnership with the team as they aim to redefine the standard of care for patients living with autoimmune and inflammatory diseases. endpoints.news/odyssey-raises…

Excited to welcome @nikhilvnamburi to the investment team at Dimension!!

Nikhil brings an investment background in compute / ML infrastructure to the team and will help the firm continue to expand our work in cutting-edge technology and science.

In addition to his domain expertise, Nikhil brings a deep curiosity for the technologies and the businesses shaping the modern internet and a passion for the craft of investing.

Welcome Nikhil!

dimensioncap.com/people/nikhil-…